Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155412 | SCV000205102 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Asp866Asn in Exon 08 of WFS1: This variant is not expected to have clinical sign ificance because it has been identified in 6.1% (5/82) of chromosomes from a pop ulation in the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP; rs38219 45). |
Eurofins Ntd Llc |
RCV000155412 | SCV000232694 | benign | not specified | 2014-06-10 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000376917 | SCV000450705 | likely benign | WFS1-Related Spectrum Disorders | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000284874 | SCV000450706 | likely benign | Autosomal dominant nonsyndromic hearing loss 6 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000155412 | SCV000515279 | benign | not specified | 2015-03-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Personalized Diabetes Medicine Program, |
RCV000664098 | SCV000787550 | likely benign | Monogenic diabetes | 2017-06-01 | criteria provided, single submitter | research | ACMG Criteria:PP3 (6 predictors), BP4 (5 predictors), BP6 (called benign by Partners, GeneDx and Emory) |
Labcorp Genetics |
RCV000871130 | SCV001012736 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002464132 | SCV002640379 | uncertain significance | Wolfram syndrome 1 | criteria provided, single submitter | research | Mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy. rs3821945 variant is also seen in patients with Diabetes Mellitus. However, the role of this particular variant is yet to be ascertained. | |
Genetics and Molecular Pathology, |
RCV002464132 | SCV002761379 | likely benign | Wolfram syndrome 1 | 2019-09-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492587 | SCV002799477 | likely benign | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2021-09-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000871130 | SCV004185216 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | WFS1: BS1, BS2 |
ARUP Laboratories, |
RCV000871130 | SCV004564837 | likely benign | not provided | 2023-11-24 | criteria provided, single submitter | clinical testing |